OPTIC Newsletter

The OPTIC newsletter is a quarterly electronic newsletter highlighting OPTIC research on key topics related to opioids, opioid policy, and opioid policy science, as well as contributions from colleagues across the country. The newsletter is free: to subscribe, fill out the form on our Contact Us page.

2020

  • Pregnant woman standing in hospital corridor, photo by WavebreakMediaMicro/Adobe Stock

    OPTIC Quarterly Newsletter, Issue 4

    Mar 9, 2020

    The RAND Opioid Policy and Tools Information Center (OPTIC) newsletter features recent work on punitive policies, differences in naloxone prescribing, other thought-provoking research across the nation, and upcoming conferences and presentations on opioid-related topics.

2019

  • Person sitting on a waiting room couch, photo by JosuOzkaritz/Getty Images

    OPTIC Quarterly Newsletter, Issue 3

    Sep 30, 2019

    The RAND Opioid Policy and Tools Information Center (OPTIC) newsletter features recent work on outpatient access to buprenorphine, the synthetic opioid surge, other thought-provoking research across the nation, and upcoming conferences and presentations on opioid-related topics.

  • A box of NARCAN nasal spray is photographed at an outpatient treatment center in Indiana, Pennsylvania, U.S. on August 9, 2017. Picture taken on August 9, 2017. Photo by Adrees Latif/Reuters

    OPTIC Quarterly Newsletter, Issue 2

    Jun 17, 2019

    The RAND Opioid Policy and Tools Information Center (OPTIC) newsletter features recent work on the ecology of neonatal abstinence syndrome (NAS), pharmacist naloxone dispensing, other thought-provoking research across the nation, and upcoming conferences and presentations on opioid-related topics.

  • Close up of a prescription bottle with Oxycodone label and white pills spilling out, photo by BackyardProduction/Getty Images

    OPTIC Quarterly Newsletter, Issue 1

    Mar 18, 2019

    The RAND Opioid Policy and Tools Information Center (OPTIC) features recent work in the opioid policy space, thought-provoking research across the nation, and upcoming conferences and presentations on opioid-related topics.